4.1 Article

Safety and exposure of once-daily ritonavir-boosted atazanavir in HIV-infected pregnant women

Related references

Note: Only part of the references are listed.
Article Infectious Diseases

Lopinavir protein binding in HIV-1-infected pregnant women

F. T. Aweeka et al.

HIV MEDICINE (2010)

Article Microbiology

Early Postpartum Pharmacokinetics of Lopinavir Initiated Intrapartum in Thai Women

Tim R. Cressey et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)

Article Immunology

Pregnancy and Optimal Care of HIV-Infected Patients

Brenna L. Anderson et al.

CLINICAL INFECTIOUS DISEASES (2009)

Article Infectious Diseases

Population analysis of the pregnancy-related modifications in lopinavir pharmacokinetics and their possible consequences for dose adjustment

Marion Bouillon-Pichault et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)

Article Immunology

Lopinavir Exposure With an Increased Dose During Pregnancy

Mark Mirochnick et al.

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2008)

Letter Immunology

Hepatotoxicity associated with nevirapine use

MS Baylor et al.

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2004)

Article Pharmacology & Pharmacy

The pharmacokinetics of nelfinavir and M8 during pregnancy and post partum

RPG van Heeswijk et al.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2004)

Review Pharmacology & Pharmacy

Pharmacokinetics of antiretrovirals in pregnant women

M Mirochnick et al.

CLINICAL PHARMACOKINETICS (2004)

Article Immunology

Concentrations of protease inhibitors in cord blood after in utero exposure

M Mirochnick et al.

PEDIATRIC INFECTIOUS DISEASE JOURNAL (2002)